Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04927338 · ClinicalTrials.gov registry record · Phase 2
Study of Bacopa in Gulf War Illness Patients
A Phase 2 study of Gulf War Illness, sponsored by Nova Southeastern University.
- Recruiting
- Registry status
- Phase 2
- Development phase
- 170
- Enrollment target
- 1
- Study location
NCT04927338: Recruiting Phase 2 study of Gulf War Illness, sponsored by Nova Southeastern University.
NCT04927338 is a Phase 2 study of Gulf War Illness that is actively recruiting participants, run by Nova Southeastern University. The registered enrollment target is 170 participants, above the 118-participant average among 14 other Gulf War Illness trials with a reported enrollment target (44% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04927338, a Phase 2 study of Gulf War Illness, is actively recruiting participants, sponsored by Nova Southeastern University.
- RECRUITING
- Registry status
- Phase 2
- Development phase
- 170 participants
- Enrollment target
- 1
- Study location
Study Summary
Gulf War Illness is a condition that affects multiple major organ systems, resulting in a diverse array of symptoms that include debilitating fatigue, memory and cognition difficulties, headaches, sleep disturbances, gastrointestinal problems, skin rashes, and musculoskeletal/joint pain. This phase II, double masked, randomized, placebo-controlled, two-arm study will evaluate cognitive function as evidence of efficacy of the nutraceutical intervention, Bacopa, on central nervous system symptom management of Gulf War Illness, along with assessments of safety of the intervention.
Primary Outcome
Change in mean CVLT-II long delay free recall from baseline to 12 weeks. Higher CVLT-II scores are considered clinically better, and the raw CVLT-II scores will be used in analyses and reporting.
Conditions Studied
Interventions
- DRUG Placebo
- DIETARY_SUPPLEMENT BacoMind® (Bacopa monnieri standardized extract)
Study Locations (1)
Florida
- Nova Southeastern University - Davie
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 170 participants |
| Start Date | 2022-12-01 |
| Est. Completion | 2026-04 |
| Phase | Phase 2 |
What NCT04927338 shows while recruiting
NCT04927338 is an interventional study that assigns participants to a tested intervention. The registered 170 participants enrollment target is mid-sized for trials with a published cap, above the 118-participant average among 14 other Gulf War Illness trials with a reported enrollment target (44% higher).
The record links to 1 condition, with Gulf War Illness appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT04927338 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT04927338 about?
NCT04927338 is a clinical study titled "Study of Bacopa in Gulf War Illness Patients". Gulf War Illness is a condition that affects multiple major organ systems, resulting in a diverse array of symptoms that include debilitating fatigue, memory and cognition difficulties, headaches, sleep disturbances, gastrointestinal problems, skin rashes, and musculoskeletal/joint pain. This phase ...
What is the current status of trial NCT04927338?
This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 170 participants. The study started on 2022-12-01. Estimated completion is 2026-04.
What conditions does trial NCT04927338 study?
This clinical trial studies the following conditions: Gulf War Illness.
What interventions are being tested in trial NCT04927338?
The interventions under investigation include: Placebo (DRUG), BacoMind® (Bacopa monnieri standardized extract) (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT04927338?
This trial is sponsored by Nova Southeastern University, which has 71 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04927338 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Gulf War Illness
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04927338's enrollment target sits among peer trials
170 3rd of 14 higher than 12 of 14 other Gulf War Illness trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Gulf War Illness trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Ca-Mg Butyrate in GWI
RECRUITING · Phase 2
-
Resistant Potato Starch to Alleviate GWI
RECRUITING · Phase 2
-
Confirmation of Diet as a Treatment for Gulf War Illness
RECRUITING · Phase 3
-
NIH Investigative Deep Phenotyping Study of Gulf War Veteran Health (Project NIH IN-DEPTH)
RECRUITING
-
Validating Gulf War Illness Blood Biomarkers
RECRUITING
-
Nicotinamide Riboside Clinical Trial for GWI
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02016430 · 170 participants · NA
Gut Flora Metabolite Reduction After Dietary Intervention (GRADY)
- NCT02621021 · 170 participants · Phase 2
A Phase 2 Trial for Metastatic Melanoma Using Adoptive Cell Therapy With Tumor Infiltrating Lymphocytes Plus IL-2 Either Alone or Following the Administration of Pembrolizumab
- NCT04094701 · 170 participants · NA
Hip Arthroscopy Postoperative Opioid Demands
- NCT04166409 · 170 participants · Phase 3
A Study of the Drugs Selumetinib vs. Carboplatin and Vincristine in Patients With Low-Grade Glioma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI